248
Views
33
CrossRef citations to date
0
Altmetric
Review

Peptide aptamers: recent developments for cancer therapy

, &
Pages 783-797 | Published online: 24 Nov 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Subramaniyan Manibalan, Kandasamy Thirukumaran, Mathimaran Varshni, Ayyasamy Shobana & Anant Achary. (2020) Report on biopharmaceutical profile of recent biotherapeutics and insilco docking studies on target bindings of known aptamer biotherapeutics. Biotechnology and Genetic Engineering Reviews 36:2, pages 57-80.
Read now
Corina Borghouts, Natalia Delis, Boris Brill, Astrid Weiss, Laura Mack, Peter Lucks & Bernd Groner. (2012) A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cells. JAK-STAT 1:1, pages 44-55.
Read now
Lauren RH Krumpe & Toshiyuki Mori. (2007) Potential of phage-displayed peptide library technology to identify functional targeting peptides. Expert Opinion on Drug Discovery 2:4, pages 525-537.
Read now
Girja S Shukla & David N Krag. (2006) Selective delivery of therapeutic agents for the diagnosis and treatment of cancer. Expert Opinion on Biological Therapy 6:1, pages 39-54.
Read now

Articles from other publishers (29)

Valery V. Veselov, Alexander E. Nosyrev, László Jicsinszky, Renad N. Alyautdin & Giancarlo Cravotto. (2022) Targeted Delivery Methods for Anticancer Drugs. Cancers 14:3, pages 622.
Crossref
Jaison Jeevanandam, Kei Xian Tan, Michael Kobina Danquah, Haobo Guo & Andrew Turgeson. (2020) Advancing Aptamers as Molecular Probes for Cancer Theranostic Applications—The Role of Molecular Dynamics Simulation. Biotechnology Journal 15:3.
Crossref
Perry Tal, Shay Eizenberger, Elad Cohen, Naomi Goldfinger, Shmuel Pietrokovski, Moshe Oren & Varda Rotter. (2016) Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides. Oncotarget 7:11, pages 11817-11837.
Crossref
Qiang Zhao & Jie Gao. (2015) Sensitive and selective detection of thrombin by using a cyclic peptide as affinity ligand. Biosensors and Bioelectronics 63, pages 21-25.
Crossref
Huijie Zhu, Jin Li, Xiao-Bing Zhang, Mao Ye & Weihong Tan. (2015) Nucleic Acid Aptamer-Mediated Drug Delivery for Targeted Cancer Therapy. ChemMedChem 10:1, pages 39-45.
Crossref
Markus Fiedler & Arne Skerra. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 435 474 .
Rayk Hassert & Annette G. Beck-Sickinger. (2013) Tuning peptide affinity for biofunctionalized surfaces. European Journal of Pharmaceutics and Biopharmaceutics 85:1, pages 69-77.
Crossref
Qiang Zhao & Jie Gao. (2013) An affinity capture involved enzymatic assay for thrombin by using peptide aptamers as affinity ligands on magnetic beads. Chemical Communications 49:70, pages 7720.
Crossref
Susanne Schmidt & Anne Debant. 2013. Inhibitors of the Ras Superfamily G-proteins, Part A. Inhibitors of the Ras Superfamily G-proteins, Part A 147 168 .
Marco Mascini, Ilaria Palchetti & Sara Tombelli. (2011) Nucleic Acid and Peptide Aptamers: Fundamentals and Bioanalytical Aspects. Angewandte Chemie International Edition 51:6, pages 1316-1332.
Crossref
Marco Mascini, Ilaria Palchetti & Sara Tombelli. (2011) Nucleinsäure‐ und Peptidaptamere: Grundlagen und bioanalytische Aspekte. Angewandte Chemie 124:6, pages 1342-1360.
Crossref
Nathalie Bouquier, Sylvie Fromont, Anne Debant & Susanne Schmidt. 2012. Rational Drug Design. Rational Drug Design 97 118 .
L. E. Petrovskaya, L. N. Shingarova, D. A. Dolgikh & M. P. Kirpichnikov. (2011) Alternative scaffold proteins. Russian Journal of Bioorganic Chemistry 37:5, pages 517-526.
Crossref
Renaud Seigneuric, Jessica Gobbo, Pierre Colas & Carmen Garrido. (2011) Targeting cancer with peptide aptamers. Oncotarget 2:7, pages 557-561.
Crossref
Hai Yun See & David P. Lane. (2010) A Novel Unstructured Scaffold Based on 4EBP1 Enables the Functional Display of a Wide Range of Bioactive Peptides. Journal of Molecular Biology 404:5, pages 819-831.
Crossref
Emma Lundberg & Mathias Uhlén. (2010) Creation of an antibody‐based subcellular protein atlas. PROTEOMICS 10:22, pages 3984-3996.
Crossref
Michael C. FlickingerHans Von Döhren. 2009. Encyclopedia of Industrial Biotechnology. Encyclopedia of Industrial Biotechnology 1 20 .
Fedor Forafonov, Elena Miranda, Ida Karin Nordgren & Ali Tavassoli. 2010. Ideas in Chemistry and Molecular Sciences. Ideas in Chemistry and Molecular Sciences 215 238 .
Andreas Plückthun. 2009. Recombinant Antibodies for Immunotherapy. Recombinant Antibodies for Immunotherapy 243 272 .
Corina Borghouts & Astrid Weiss. 2009. Peptides as Drugs. Peptides as Drugs 145 186 .
Caroline Grönwall & Stefan Ståhl. (2009) Engineered affinity proteins—Generation and applications. Journal of Biotechnology 140:3-4, pages 254-269.
Crossref
Carine Bardou, Christophe Borie, Marc Bickle, Brian B. Rudkin & Pierre Colas. 2009. Nucleic Acid and Peptide Aptamers. Nucleic Acid and Peptide Aptamers 373 388 .
Christian Dohmen & Manfred Ogris. 2009. Pharmaceutical Perspectives of Cancer Therapeutics. Pharmaceutical Perspectives of Cancer Therapeutics 269 295 .
Bernd Groner, Peter Lucks & Corina Borghouts. (2008) The function of Stat3 in tumor cells and their microenvironment. Seminars in Cell & Developmental Biology 19:4, pages 341-350.
Crossref
Arne Skerra. (2007) Alternative non-antibody scaffolds for molecular recognition. Current Opinion in Biotechnology 18:4, pages 295-304.
Crossref
Ali Tavassoli & Stephen J Benkovic. (2007) Split-intein mediated circular ligation used in the synthesis of cyclic peptide libraries in E. coli. Nature Protocols 2:5, pages 1126-1133.
Crossref
Markus Fiedler & Arne Skerra. 2007. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 467 499 .
Evangelia Tomai, Karin Butz, Claudia Lohrey, Fritz von Weizsäcker, Hanswalter Zentgraf & Felix Hoppe-Seyler. (2006) Peptide Aptamer-mediated Inhibition of Target Proteins by Sequestration into Aggresomes. Journal of Biological Chemistry 281:30, pages 21345-21352.
Crossref
Corina Borghouts, Christian Kunz & Bernd Groner. (2005) Current strategies for the development of peptide‐based anti‐cancer therapeutics. Journal of Peptide Science 11:11, pages 713-726.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.